Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Murray

Showing results (1381-1390 of 1,465) with videos related to

Pageof 147
Sort By:
Pediatrics|January 22, 2014
Mortality and morbidity of VLBW infants with trisomy 13 or trisomy 18Nansi S Boghossian, Nellie I Hansen, Edward F Bell, et al.
Plos One|February 12, 2014
Evidence of gene-environment interaction for two genes on chromosome 4 and environmental tobacco smoke in controlling the risk of nonsyndromic cleft palateTao Wu, Holger Schwender, Ingo Ruczinski, et al.
Science (New York, N.Y.)|October 23, 2010
Diviner Lunar Radiometer observations of cold traps in the Moon's south polar regionDavid A Paige, Matthew A Siegler, Jo Ann Zhang, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
Rare variants in <i>PRKCI</i> cause Van der Woude syndrome and other features of peridermopathyKelsey Robinson, Sunil K Singh, Rachel B Walkup, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2024
Multi-ancestry Genome Wide Association Study Meta-analysis of Non-syndromic Orofacial CleftsZhonglin Jia, Nandita Mukhopadhyay, Zhenglin Yang, et al.
Nature Genetics|September 10, 2002
Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromesShinji Kondo, Brian C Schutte, Rebecca J Richardson, et al.
Journal of Medicinal Chemistry|March 18, 2015
Utilizing structures of CYP2D6 and BACE1 complexes to reduce risk of drug-drug interactions with a novel series of centrally efficacious BACE1 inhibitorsMichael A Brodney, Elizabeth M Beck, Christopher R Butler, et al.
Blood|June 30, 2026
TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosisNaveen Pemmaraju, Adam J Mead, Tim C P Somervaille, et al.
Human Molecular Genetics|September 26, 2009
FOXE1 association with both isolated cleft lip with or without cleft palate, and isolated cleft palateLina M Moreno, Maria Adela Mansilla, Steve A Bullard, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancerJoseph C Murray, Lavanya Sivapalan, Karlijn Hummelink, et al.
Pageof 147

Showing results (1381-1390 of 1,465) with videos related to

Sort By:
Pageof 147
Pediatrics|January 22, 2014
Mortality and morbidity of VLBW infants with trisomy 13 or trisomy 18Nansi S Boghossian, Nellie I Hansen, Edward F Bell, et al.
Plos One|February 12, 2014
Evidence of gene-environment interaction for two genes on chromosome 4 and environmental tobacco smoke in controlling the risk of nonsyndromic cleft palateTao Wu, Holger Schwender, Ingo Ruczinski, et al.
Science (New York, N.Y.)|October 23, 2010
Diviner Lunar Radiometer observations of cold traps in the Moon's south polar regionDavid A Paige, Matthew A Siegler, Jo Ann Zhang, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
Rare variants in <i>PRKCI</i> cause Van der Woude syndrome and other features of peridermopathyKelsey Robinson, Sunil K Singh, Rachel B Walkup, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2024
Multi-ancestry Genome Wide Association Study Meta-analysis of Non-syndromic Orofacial CleftsZhonglin Jia, Nandita Mukhopadhyay, Zhenglin Yang, et al.
Nature Genetics|September 10, 2002
Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromesShinji Kondo, Brian C Schutte, Rebecca J Richardson, et al.
Journal of Medicinal Chemistry|March 18, 2015
Utilizing structures of CYP2D6 and BACE1 complexes to reduce risk of drug-drug interactions with a novel series of centrally efficacious BACE1 inhibitorsMichael A Brodney, Elizabeth M Beck, Christopher R Butler, et al.
Blood|June 30, 2026
TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosisNaveen Pemmaraju, Adam J Mead, Tim C P Somervaille, et al.
Human Molecular Genetics|September 26, 2009
FOXE1 association with both isolated cleft lip with or without cleft palate, and isolated cleft palateLina M Moreno, Maria Adela Mansilla, Steve A Bullard, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancerJoseph C Murray, Lavanya Sivapalan, Karlijn Hummelink, et al.
Pageof 147